[1] Kaplan NM, Sproul LE, Mulcahy WS. Large prospective study of ramipril in patients with hypertension. CARE Investigators. Clin Ther 1993;15(5):810-8. https://pubmed.ncbi.nlm.nih.gov/8269447.
[2] United States of America Congress. 21st Century cures act. 2016. https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf. [2023-6-11].
[3] U.S. Food and Drug Administration. Framework for FDA’s real-world evidence program. 2018. https://www.fda.gov/media/120060/download?attachment. [2023-2-23].
[4] European Medicines Agency. ICH Reflection paper on proposed international harmonisation of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data, with a focus on effectiveness of medicines. 2023. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-reflection-paper-proposed-international-harmonisation-real-world-evidence-terminology_en.pdf. [2023-8-19].
[5] Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169(7):467 − 73. https://doi.org/10.7326/M18-0850CrossRef
[6] Klinger G, Chodick G, Levy I. Long-term immunity to hepatitis B following vaccination in infancy: real-world data analysis. Vaccine 2018;36(17):2288 − 92. https://doi.org/10.1016/j.vaccine.2018.03.028CrossRef
[7] Wang XL, An ZJ, Huo D, Jia L, Li J, Yang Y, et al. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Hum Vaccin Immunother 2019;15(5):1183 − 90. https://doi.org/10.1080/21645515.2019.1581539CrossRef
[8] Marshall HS, Koehler AP, Wang B, A’Houre M, Gold M, Quinn H, et al. Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine 2020;38(37):5914 − 22. https://doi.org/10.1016/j.vaccine.2020.07.009CrossRef
[9] Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016;183(8):758 − 64. https://doi.org/10.1093/aje/kwv254CrossRef
[10] Dickerman BA, Gerlovin H, Madenci AL, Kurgansky KE, Ferolito BR, Figueroa Muñiz MJ, et al. Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U. S. veterans. N Engl J Med 2022;386(2):105 − 15. https://doi.org/10.1056/NEJMoa2115463CrossRef
[11] Al Kaabi N, Oulhaj A, Ganesan S, Al Hosani FI, Najim O, Ibrahim H, et al. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates. Nat Commun 2022;13(1):3215. https://doi.org/10.1038/s41467-022-30835-1CrossRef
[12] Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernán MA, et al. Fourth dose of BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med 2022;386(17):1603 − 14. https://doi.org/10.1056/NEJMoa2201688CrossRef
[13] National Medical Products Administration of China. Real-world data used to generate real-world evidences (Interim). 2021. https://www.cde.org.cn/main/news/viewInfoCommon/2a1c437ed54e7b838a7e86f4ac21c539. [2023-5-28]. (In Chinese). 
[14] U.S. Food and Drug Administration. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products. 2023. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug. [2023-8-31].